Fecha de publicación: -- Fuente: Biotechblog Lugar: General Biotechnology Stop Calling It Loss of Exclusivity for Most DrugsIts Loss of Pricing Power, Not Revenue
For years, the industry has repeated a soothing phrase: loss of exclusivity. It sounds clinical, inevitable, almost benignlike a patent clock running out and nothi...
Source